Introduction Container Closure Integrity Testing (CCIT) for Generic Sterile Drug Products is a critical process used to confirm that a […]
Introduction CDMO Services for Generic Topical and Semisolid Drug Products provide the specialized formulation development, analytical characterization, and manufacturing capabilities
Introduction Bioequivalence study design for complex generic drug products requires a comprehensive and integrated development strategy that combines precise qualitative/quantitative
Introduction Outsourcing Extractables and Leachables (E&L) Testing to a Drug Establishment License (DEL) holder ensures that analytical data is generated
Introduction Formulating a Lyophilized Peptide Injectable involves the strategic design of a solid-state glass matrix capable of maintaining peptide chemical
Introduction Establishing analytical similarity is a fundamental requirement for obtaining regulatory approval of biosimilar therapeutic proteins. A comprehensive Biosimilar Comparability
Introduction The development of a multiplexed bioanalytical panel for a combination immunotherapy clinical program requires the simultaneous quantitative assessment of
Introduction: Nitrosamine Risk Assessment for Combination Oral Solid Dosage Forms is particularly important when a pharmaceutical product contains two or
Introduction: Hybrid LBA/LC-MS/MS Assays for Large Molecule Quantification provide a powerful analytical strategy when neither a conventional ligand-binding assay nor
Peptide Characterization Chiral Analysis of Therapeutic Peptide APIs: D-Amino Acid Detection by LC-MS and Enzymatic Digestion By Anusha Sinha •
